Pulsed Field Ablation of Persistent Atrial Fibrillation With Continuous Electrocardiographic Monitoring Follow-Up: ADVANTAGE AF Phase 2.

Saved in:
Bibliographic Details
Title: Pulsed Field Ablation of Persistent Atrial Fibrillation With Continuous Electrocardiographic Monitoring Follow-Up: ADVANTAGE AF Phase 2.
Authors: Reddy VY; Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, NY (V.Y.R., M.K.T.)., Gerstenfeld EP; University of California San Francisco (E.P.G.)., Schmidt B; Cardioangiologisches Centrum Bethanien, Frankfurt, Germany (B.S.)., Andrade JG; MercyOne Iowa Heart Center, West Des Moines (T.H.)., Nair D; St. Bernards Medical Center and Arrhythmia Research Group, Jonesboro, AR (D.N.)., Natale A; Texas Cardiac Arrhythmia Research, Austin (A.N.).; Case Western Reserve University, Cleveland, OH (A.N.).; Department of Biomedicine and Prevention, Division of Cardiology, University of Tor Vergata, Rome, Italy (A.N.)., Saliba W; Cleveland Clinic Foundation, OH (W.S.)., Sommer P; Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany (P.S.).; Ruhr-University Bochum, Germany (P.S.)., Metzner A; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany (A.M.)., Verma A; McGill University Health Centre, Montreal, QC, Canada (A.V.)., Hounshell T; MercyOne Iowa Heart Center, West Des Moines (T.H.)., Amin A; Riverside Methodist Hospital, Upper Arlington, OH (A.A.)., Gentlesk P; Sentara Cardiology, Norfolk, VA (P.G.)., Weiner S; Christus Trinity Mother Frances Health System, Tyler, TX (S.W.)., Cuoco FA; Trident Medical Center, Charleston, SC (F.A.C.)., Kim J; Catholic Medical Center, Manchester, NH (J.K.)., Turagam MK; Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, NY (V.Y.R., M.K.T.)., Tomassoni G; Baptist Health Lexington, KY (G.T.)., Patel C; University of Pittsburg Medical Center, Harrisburg, PA (C.P.)., Issa Z; Saint John's Hospital, Springfield, IL (Z.I.)., Shehata M; Cedars-Sinai Medical Center, Los Angeles, CA (M.S.)., Anderson AM; Boston Scientific Corp, St. Paul, MN (A.M.A., T.J.S., J.D.R., T.S., B.S.S.)., Stoltz TJ; Boston Scientific Corp, St. Paul, MN (A.M.A., T.J.S., J.D.R., T.S., B.S.S.)., Raybuck JD; Boston Scientific Corp, St. Paul, MN (A.M.A., T.J.S., J.D.R., T.S., B.S.S.)., Schwartz T; Boston Scientific Corp, St. Paul, MN (A.M.A., T.J.S., J.D.R., T.S., B.S.S.)., Sutton BS; Boston Scientific Corp, St. Paul, MN (A.M.A., T.J.S., J.D.R., T.S., B.S.S.)., Mansour M; Massachusetts General Hospital, Boston (M.M.).
Corporate Authors: ADVANTAGE AF Investigators
Source: Circulation [Circulation] 2025 Jul 08; Vol. 152 (1), pp. 27-40. Date of Electronic Publication: 2025 Apr 24.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4539
DOI:10.1161/CIRCULATIONAHA.125.074485